Vancomycin utilization at a teaching hospital in Hong Kong

被引：6
作者：
You, JHS [1 ]
Lyon, DJ
Lee, BSC
Kwan, SM
Tang, HY
机构：
[1] Chinese Univ Hong Kong, Fac Med, Sch Pharm, Shatin, Hong Kong, Peoples R China
[2] Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China
[3] Prince Wales Hosp, Dept Pharm, Hong Kong, Hong Kong, Peoples R China
[4] Hosp Author, Hong Kong, Hong Kong, Peoples R China
来源：
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2001年 / 58卷 / 22期
关键词：
D O I：
10.1093/ajhp/58.22.2167
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：2167 / 2169
页数：3
相关论文
共 7 条
  • [1] *HOSP INF CONTR PR, 1995, MMWR-MORBID MORTAL W, V44, P1
  • [2] INAPPROPRIATE VANCOMYCIN PRESCRIBING BASED ON CRITERIA FROM THE CENTERS-FOR-DISEASE-CONTROL AND PREVENTION
    JOHNSON, SV
    HOEY, LL
    VANCEBRYAN, K
    [J]. PHARMACOTHERAPY, 1995, 15 (05): : 579 - 585
  • [3] First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital
    Ploy, MC
    Grélaud, C
    Martin, C
    de Lumley, L
    Denis, F
    [J]. LANCET, 1998, 351 (9110) : 1212 - 1212
  • [4] Bacteremia caused by staphylococci with inducible vancomycin heteroresistance
    Wong, SSY
    Ho, PL
    Woo, PCY
    Yuen, KY
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (04) : 760 - 767
  • [5] 1997, MMWR, V46, P813
  • [6] 2000, MMWR, V48, P1165
  • [7] 1997, MMWR, V46, P624
1